MIP Diagnostics Limited develops and manufactures nanoMIPs, linear MIPs, bulk MIP and Rationally Designed Polymers using its proprietary processes.
Molecularly Imprinted Polymers (MIPs) are ‘synthetic’ affinity reagents and the nanoMIP format provides a more robust alternative to antibodies, typically with similar or greater affinity coupled with additional unique characteristics.
Business funding insights
A decade of hard work coming to fruition? Just look at our investments and exits
Far from slowing down as a result of the coronavirus pandemic, BGF’s investment activity has stepped up both in pace and volume.
Exit strategies: how to get the timing and valuation right
More than 100 BGF-backed businesses have achieved exits. Our panel of experts discuss the exit strategies that are proven to succeed.